Participants were randomized to receive prophylactic treatment with @ mg of dexamethasone and a @HT@ receptor antagonist ( RA ) on the day of chemotherapy , followed by gabapentin @ mg twice a day and dexamethasone ( dex ) or placebo and dex after HEC .